secwatch.observer — SEC 8-K summary
======================================

Issuer:     ASHLAND INC. (ASH)
CIK:        0001674862
Form:       8-K
Filed at:   2024-11-06T23:59:59+00:00
Accession:  0000950170-24-122475
Event type: earnings
Sentiment:  neutral
Materiality: 0.65
Item codes: 2.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Ashland Q4 sales $522M (+1% YoY), adj. EBITDA $124M (+68%), issues FY2025 outlook
--------------------------------------------------------------------------------

- Sales $522M, up 1% YoY; nutraceuticals divestiture and CMC/MC curtailments reduced sales ~$24M (5%).
- Adjusted EBITDA $124M (+68% YoY); below expectations due to HEC startup issues (~$5M) and weak China coatings demand.
- Net income $16M vs $(4)M; adjusted EPS ex-intangibles $1.26, up from $0.41 YoY.
- Bought back 1.7M shares in Q4; $620M remains under evergreen authorization. Cash from ops $80M; ongoing FCF $88M.
- Sold nutraceuticals to Turnspire Capital; production at U.S. cellulosic site normalized early October.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1674862/000095017024122475/0000950170-24-122475-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1674862/000095017024122475/ash-20241106.htm
  HTML page:      https://secwatch.observer/filing/0000950170-24-122475

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer